X

SEARCH

Leadership

Get to know our team

Crossix sets the standard for healthcare data analytics, and our leaders set the standard for us. They have decades of combined experience and an unrivaled track record of healthcare & analytics innovation.

Executive Leadership Team
  • Peter Frishauf

    Peter Frishauf

    Non-executive Chairman
    of the Board

    Peter Frishauf

    Non-executive Chairman of the Board

    Peter is best known as the founder of Medscape. At the time he served as CEO of SCP Communications, Inc. Peter was inducted into the Medical Advertising Hall of Fame in 2013, and has been listed as one of the 1,000 most creative people in the U.S. He is past president of the Healthcare Marketing & Communications Council, Inc. He is a director of Crossix and Context Matters, and a member of the Medical Advisory Boards of Everyday Health, Milestone Venture Partners, TrialX and the Markle Foundation's Connecting for Health initiative. A frequent guest speaker and widely published author, Peter holds an M.S. in journalism from Columbia University and a B.A. from New York University.

  • Asaf Evenhaim

    Asaf Evenhaim

    Co-founder, CEO;
    Board Member

    Asaf Evenhaim

    Co-founder, CEO; Board Member

    Asaf is a co-founder of Crossix and serves as Chief Executive Officer. He started Crossix in 2004 with more than 10 years’ experience in healthcare marketing and technology businesses. Asaf has been named to the PharmaVOICE 100 most influential people in the life sciences industry and a PM360 ELITE honoree. Before founding Crossix, he was the co-founder and president of SoftWatch, a healthcare CRM provider. Asaf also served as acting CEO for Dietwatch.com, an online subscription weight loss company spun off from SoftWatch. Earlier, Asaf served as EVP of Business Development for InterCure Inc, a medical device company. Asaf served for four years in the Israeli Navy Intelligence Unit and he holds a B.S. in mathematics and computer science from Tel Aviv University.

  • Andrew Willis

    Andrew Willis

    Co-founder, EVP and CFO;
    Board Member

    Andrew Willis

    Co-founder, EVP and CFO; Board Member

    Andrew is a co-founder of Crossix and serves as Executive Vice President and Chief Financial Officer. Andrew joined Crossix in 2004 from a career in investment banking focused on healthcare companies, most recently having helped to establish a Private Finance group at NM Rothschild in London. Before that, Andrew worked at Credit Suisse, both in the Private Finance group where he focused on raising private capital for companies, and in the Healthcare team working with a wide range of public and private healthcare clients on capital and M&A transactions. He received his B.S.B.A. from Georgetown University, his M.B.A. from Columbia Business School and his J.D. from Columbia University School of Law. Andrew serves as Co-chair of the Montefiore Einstein Council at Montefiore Medical Center and is a member of the New York State Bar.

  • Dan Stein

    Dan stein

    SVP, Analytics Services &
    Product Strategy

    Dan Stein

    SVP, Analytics Services & Product Strategy

    Dan serves as Senior Vice President, Analytics Services & Product Strategy, responsible for driving innovation across the Crossix product suite, including digital and TV-based solutions. In 2017, Dan was named a PM360 ELITE Award honoree for his contributions to the healthcare industry. Dan brings more than 16 years of digital, direct, and healthcare marketing experience to Crossix. Previously, Dan led a Strategy and Analysis group at Digitas and Digitas Health. At Digitas Health, Dan built a team focused on leveraging analytics to help pharma and health-focused clients optimize their marketing plans and partnerships. Prior experience in marketing and healthcare consulting was achieved at Scholastic and PricewaterhouseCoopers. Dan holds a B.A. in economics from the University of Pennsylvania.

  • Saar Barhoom

    Saar barhoom

    SVP, Research &
    Development

    Saar Barhoom

    SVP, Research & Development

    Saar serves as Senior Vice President, Research & Development. He joined Crossix in 2005 from Itemfield Ltd, a leader in enterprise application interfaces. Saar brings more than 22 years of software development experience, including in healthcare IT, to Crossix. Saar previously worked for Excedo Technologies, a startup in Business Activity Monitoring market, and was VP R&D and Chief Architect at SoftWatch. Saar has extensive managerial and hands-on experience with Java and Microsoft's enterprise architecture infrastructures. He holds a B.A. in computer science and an M.B.A from Tel Aviv University.

  • Jeff Davis

    Jeff Davis

    SVP, Business Development

    Jeff Davis

    SVP, Business Development

    Jeff serves as Senior Vice President, Business Development, for the Crossix suite of analytics products and services. His focus is creating optimal partnerships with healthcare clients and agencies, enabling insights, innovation, and effectiveness. Jeff brings 20 years of healthcare experience to Crossix, including HCP, DTC, software, and analytics. He has held senior sales and business development positions at Zinc Ahead (now Veeva), PDR Network, Phreesia and WebMD, focusing on the enablement of precision commercial, marketing and media investments.

  • Sarah Caldwell

    Sarah caldwell

    VP, Analytics Services

    Sarah Caldwell

    VP, Analytics Services

    Sarah serves as a Vice President, Analytics Services at Crossix and has more than 10 years of experience in pharmaceutical marketing analytics. Sarah joined Crossix in 2007 and has consulted with pharmaceutical brands across various therapeutic areas and business situations, including launch and loss of exclusivity. Sarah has strong knowledge of professional and patient data issues, and extensive experience with measurement and optimization of pharmaceutical consumer marketing investments. Sarah holds a B.S. in management information systems from Saint Joseph’s University.

  • Shannon Gallagher

    Shannon Gallagher

    VP, Analytics Services

    Shannon Gallagher

    VP, Analytics Services

    Shannon Gallagher serves as Vice President, Analytics Services at Crossix and has more than 15 years of analytics and consulting experience in pharmaceutical media and marketing effectiveness. Prior to joining Crossix in 2012, Shannon spent more than 10 years with Nielsen where she was a leader in BASES Pharmaceutical Practice Area. Shannon is a highly sought-after speaker at industry conferences, including DTC National, PMSA, and ePharma. She serves as Vice President of the Board of the New York City chapter for the Alliance for Women in Media. Shannon holds a BA in Comparative Literature from Cornell University.

  • Jeremy Mittler

    Jeremy mittler

    VP, Industry Solutions

    Jeremy Mittler

    VP, Industry Solutions

    Jeremy serves as Vice President, Industry Solutions at Crossix, having joined the company in 2008. In his current role, Jeremy is involved in nearly all aspects of Crossix’s commercial activities, Crossix subject-matter support, strategic partnership discussions, and the development of future Crossix offerings. Jeremy has a deep understanding of the innovative marketing analytics Crossix brings to its pharmaceutical brands, publishers and other clients and how they help to measure and optimize the range of campaigns and tactics in the marketplace. Jeremy has more than 15 years of pharmaceutical and healthcare analytics and consulting experience, having previously worked at Synygy and Campbell Alliance with many of the top pharmaceutical companies. He holds a B.A. in economics from the University of Rochester and an M.B.A. from New York University Stern School of Business.

  • Chris Meyer

    Chris Meyer

    VP, People & Culture

    Chris Meyer

    VP, People & Culture

    Chris serves as the Vice President of People & Culture at Crossix, where he oversees the company's employment brand to attract top-level talent as Crossix continues to grow and enter new markets. Chris is a 20-year talent veteran with specialized expertise in driving growth for progressive companies in the technology and digital media sectors. Prior to Crossix, he served as the lead HR business partner for the sales, customer success and marketing divisions of Rocket Fuel, a leading ad tech company. He also held several senior HR roles at various WPP-owned media agencies. Chris holds a B.S. degree in industrial and labor relations from Cornell University.

  • Whitney Kemper

    Whitney Kemper

    VP, Analytics Products

    Whitney Kemper

    VP, Analytics Products

    Whitney Kemper serves as VP, Analytics Products at Crossix Solutions, which he joined in 2009. He leads the development of Crossix's analytical frameworks as well as the implementation of new technology and data. Whitney's extensive experience with data and marketing analytics allows him to navigate the challenges of integrating and gleaning meaning from the wide array of healthcare, media, and consumer data that Crossix employs. He holds a B.A. in Economics, English, and East Asian Studies from Vanderbilt University.

Advisory Board
  • Robert Williams

    Robert Williams

    Co-founder Medialytic;
    Advisory Board Member

    Robert Williams

    Co-founder of Medialytic; Advisory Board Member

    Bob is a serial media entrepreneur with a 20-year record of successful start-up media businesses. He helped found The Real Paper, a Boston weekly newspaper which spawned the film Between the Lines. He is the Founder of National Cable Advertising, which grew to become NCC Media, now owned by Comcast, Time Warner and Cox. He then founded National Public Broadcasting (representing all the PBS and NPR stations in the US), now known as National Public Media, and owned by NPR, PBS and WGBH. Bob holds a B.A. from Case Western Reserve University.

  • Matt Dumas

    matt dumas

    Advisory Board Member

    Matt Dumas

    Advisory Board Member

    Matt was most recently SVP and head of marketing for WebMD. Prior to that he was co-founder of Ecosys Consumer Analytics LLC, a subsidiary of Crossix. Matt brings more than 20 years of experience leading new ventures and turnarounds in consumer health and information services. Prior to Ecosys, he founded Deutsche Ventures Corp, a new venture incubator and marketing innovation consulting practice, focused on data analytics enabling accountable marketing for consumer health advertisers. Previously, Matt was the founder and managing director of Nielsen Health. Matt also spent 10 years at Procter & Gamble in global brand management . Matt holds a M.B.A. from the University of Michigan Ross School of Business and a B.A. from Colby College.

  • Drew Fromkin

    drew fromkin

    Advisory Board Member

    Drew Fromkin

    Advisory Board Member

    Drew has more than 25 years of leadership experience in major areas of the healthcare industry with an emphasis in the life sciences, biopharmaceutical, and healthcare services sectors. Most recently, Drew was named CEO of Blend Therapeutics. Prior to Blend Therapeutics, Drew served as president, CEO and director of Clinical Data, Inc., which was acquired by Forest Laboratories for more than $1.2B. While at Clinical Data, Drew was named to BusinessWeek’s “CEOs 40 and Under.” Drew has also served as president and CEO of DoctorQuality, Inc. (acquired by Quantros, Inc.); president, CEO and director of Endo Surgical Devices, Inc.; and corporate vice president, business development for Merck-Medco. Inc. Drew holds a B.A. in biology from Brandeis University.

  • Matt Wallach

    matt wallach

    Advisory Board Member

    Matt Wallach

    Advisory Board Member

    Matt co-founded and currently serves as President of Veeva Systems (NYSE:VEEV), a leader in cloud-based software for the global life sciences industry. In 2007, Matt was named to the PharmaVOICE 100 which recognizes the 100 most influential people in the life sciences industry. Before founding Veeva, Matt held various executive roles at small healthcare technology companies in product management, marketing and business development. Prior to his small company forays, Matt was the General Manager of the Pharmaceuticals & Biotechnology division at Siebel Systems, which has since been acquired by Oracle. Matt received his MBA from the Harvard Business School, with honors, and his B.A. in Economics from Yale University, cum laude.